Munich (ots/PRNewswire) - In the news release, "World?s First Curve(TM) Image Guided Surgery System Now Operating in Germany" issued on 15 Dec 2011 09:12 GMT, by Brainlab AG over PR Newswire, we are advised by a representative of the company that some minor changes were required to be made within the first paragraph ...
Munich (ots/PRNewswire) - Highly advanced surgical navigation system to enable faster, more precise and safer surgery This week, university hospital Klinikum rechts der Isar in Munich, Germany, is the first hospital in the world to operate with Brainlab's Curve(TM) Image Guided Surgery system. The new technology is hoped to provide surgeons with the best possible ...
Zutphen, The Netherlands (ots/PRNewswire) - It is part of Cryo-Save's educational program deployment to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals. The Second international congress "Regenerative medicine - stem cells, genetic engineering and ...
http://resources.euroadhoc.com/us/rmvkjJOh issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Munich (ots/PRNewswire) - Pooled results of the STARS E-III and STARS J-V studies presented at the 2011 American Society of Hematology (ASH) Annual Meeting Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the results of a pooled analysis showing that edoxaban*, a direct oral once-daily ...
Zurich, Switzerland (ots) - NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports ...
Takeda Pharmaceutical Company Limited
London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi(R) (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist ...
Paris (ots/PRNewswire) - Two studies presented at World Diabetes Congress 2011 provide further evidence of the benefits to patients of early glycemic control on co-morbidities Sanofi announced today new results from sub-analyses of the First Basal INsulin Evaluation in Asia (FINE Asia) Registry study,[1] and the Cardiovascular Risk Evaluation in People with Type 2 ...
London, November 30 (ots/PRNewswire) - Multi-Center Procedure Data Presented in Over 1700 Cases Using the Sensei(R) X Robotic Catheter System Hansen Medical, UK Ltd, a subsidiary of Hansen Medical, Inc., , a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of ...
Bristol-Myers Squibb and AstraZeneca
Paris and London, November 29 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for KOMBOGLYZETM (saxagliptin and metformin HCl immediate-release fixed dose combination) that will cover the 27 Member States of the European ...
Melbourne, Australia, November 28 (ots/PRNewswire) - Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule. The investment is not expected to have any material impact on Ansell's earnings per share in Fiscal Years 2012 and 2013. Further, Ansell and Yulex executed an exclusive agreement for ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris, November 25 (ots/PRNewswire) - - REYATAZ(R) is the only boosted PI to include dosing and medical guidance in pregnancy and postpartum in the label - Bristol-Myers Squibb Company today announced that the European Commission approved a labelling update for REYATAZ(R) (atazanavir sulfate) based on new data ...
http://resources.euroadhoc.com/us/BdZOgnI9 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Zutphen, the Netherlands, November 22 (ots/PRNewswire) - This landmark storage of the 200,000th stem cell sample indicates a step forward in Cryo-Save's leading role in the cord blood industry Cryo-Save is proud to announce the storage of its 200,000th sample. This great achievement shows the successful results of ...
GENEVA and PLAN- LES-OUATES, Switzerland, November 21, 2011 (ots/PRNewswire) -- BELOTERO Balance(R) has now been approved by the US Food and Drug Administration (FDA) for injection into the mid-to-deep dermis to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds. BELOTERO Balance(R) is a hyaluronic acid-based cohesive gel dermal filler that ...
London, November 18 (ots/PRNewswire) - AstraZeneca today announced that the Marketing Authorisation Application for CAPRELSA (vandetanib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of aggressive and symptomatic medullary thyroid cancer (MTC) in ...
Montreal, November 16 (ots/PRNewswire) - Sunshine Biopharma Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has successfully completed the preclinical studies for Adva-27a, the ...
London, November 15 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials [http://www.evaluatepharma.com/clinical ][SM]. By linking EudraCT [https://eudract.ema.europa.eu ] and ...
RED BANK, New Jersey, MELBOURNE, Australia, and BRUSSELS, November 15, 2011 (ots/PRNewswire) -- In just 15 years, Ansell's best-selling brand sells 500M pairs worldwide Ansell, global leader in health and safety solutions with over a century of expertise, has today reached a historic milestone - the sale of its 500 millionth pair of HyFlex(R) gloves. Since its creation, the HyFlex [http://www.ansell.com/corporate/ ...
Paris, November 15 (ots/PRNewswire) - CRI's Amigo(TM) system allows remote control of Boston Scientific's leading cardiac ablation catheters Boston Scientific Corporation is beginning to market the CRI Amigo(TM) system, a remote-controlled catheter system, and related accessories in select European countries through ...
Paris, November 9 (ots/PRNewswire) - Now available for endoscopic dilation of the Sphincter of Oddi following sphincterotomy Boston Scientific Corporation's CRE(TM) Wireguided Balloon Dilator is now CE marked for endoscopic dilation of the Sphincter of Oddi following sphincterotomy. The new indication, which supplements the product's current indication for use in the ...
http://resources.euroadhoc.com/us/ToCwLq5B http://resources.euroadhoc.com/us/o1izYpb6 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 ...
SURESNES, France and MONTRÉAL, November 8, 2011 (ots/PRNewswire) - Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment. This ...
DNDi - Drugs for Neglected Diseases initiative
Geneva, Switzerland/New Delhi, India (ots) - A comprehensive four-year project including over 10,000 patients in clinical and pharmacovigilance studies for diagnosis and treatment of visceral leishmaniasis (VL, also known as kala-azar) in India and Bangladesh was launched by an international consortium formed last ...
BRUSSELS, REDBANK, New Jersey and MELBOURNE, Australia, November 4, 2011 (ots/PRNewswire) -- Contact: Media, Wouter Piepers, GCC-Ansell, Tel: (00322) 5287400, wpiepers@eu.ansell.com, US - Jeff Picarello, Edelman PR, Tel:(1212)7048244, jeff.picarello@edelman.com, I.R., David Graham, I.R.-Ansell, Tel:(613)92707215, ...
issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: ...
Hilden, Germany, and Gaithersburg, Md. (ots) - Vaginal self-collection for Hybrid Capture®-based HPV testing increases screening coverage and is more sensitive than Pap smear shows a Mexican study published today online in the Lancet Promising findings published today online in the Lancet[i] from a community- based, randomized equivalence trial undertaken by public ...
Geneva, Switzerland (ots) - In an article published today in the European Respiratory Journal, results from a study on electronic cigarettes show users get as much nicotine from this product as smokers usually get from tobacco cigarettes. The study, by researchers from the Universities of Geneva and Auckland, reports levels of cotinine (a product of the degradation of ...
London, November 1 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply reliable consensus forecasts of global drug sales, revealed today that Sanofi is expected to take the top spot amongst the world's pharmaceuticals manufacturers in 2012 and hold it through 2016. The French drug maker has raced up the rankings over the last decade largely through M&A activity, ...
Plan-les-Ouates, Switzerland (ots) - Viroblock S.A., a company with a highly innovative, broadly applicable anti-viral air filtration technology, initially focused on development and commercialization of anti-viral face-masks, today announced the successful closure of a 3.3 million CHF Series C financing round. Dr Jamie Paterson, CEO of Viroblock, said "these funds allow Viroblock to complete the development of our ...